132 related articles for article (PubMed ID: 8504717)
21. [Pathology of myeloproliferative disorders and related diseases].
Motoi M
Rinsho Ketsueki; 1988 Jul; 29(7):969-76. PubMed ID: 3184483
[No Abstract] [Full Text] [Related]
22. Management of myelofibrosis--where next?
Qureshi M; Harrison C
Expert Opin Pharmacother; 2011 Jul; 12(10):1453-5. PubMed ID: 21651445
[No Abstract] [Full Text] [Related]
23. Morphological studies on the bone tissue of sternum in osteomyelosclerosis, panmyelosis and chronic myeloleukosis.
Velizarov A; Valkov I
Nauchni Tr Vissh Med Inst Sofiia; 1970; 49(3):61-71. PubMed ID: 4253273
[No Abstract] [Full Text] [Related]
24. Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.
Pullarkat V; Bass RD; Gong JZ; Feinstein DI; Brynes RK
Am J Hematol; 2003 Jan; 72(1):8-12. PubMed ID: 12508261
[TBL] [Abstract][Full Text] [Related]
25. Idiopathic myelofibrosis. Clinical aspects and studies on extracellular matrix metabolism.
Hasselbalch HC
Dan Med Bull; 1993 Mar; 40(1):39-55. PubMed ID: 8472598
[No Abstract] [Full Text] [Related]
26. Treatment of myeloproliferative diseases.
Sellei C
Ther Hung; 1966; 14(4):135-6. PubMed ID: 5228101
[No Abstract] [Full Text] [Related]
27. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
Thiele J; Kvasnicka HM
Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
[TBL] [Abstract][Full Text] [Related]
28. The spleen as a source of colony-forming cells in myelofibrosis.
Adamson JW; Powell JS
Prog Clin Biol Res; 1984; 154():323-34. PubMed ID: 6382301
[No Abstract] [Full Text] [Related]
29. [Secondary myeloid splenomegalies and accompanying myeloid splenomegalies].
Gallais H; Casanova P; Muratore R; Olmer J
Nouv Presse Med; 1972 Apr; 1(16):1063-4. PubMed ID: 5035860
[No Abstract] [Full Text] [Related]
30. [Delimitation of ostoeomyelosclerosis and sarcomatosis].
Rothenberger W; Klöppel G
Med Klin; 1972 Nov; 67(45):1480-4. PubMed ID: 4637698
[No Abstract] [Full Text] [Related]
31. Myelofibrosis and myeloid tumors as a surgical disease.
French WE; Yates DR
South Med J; 1970 Apr; 63(4):387-91. PubMed ID: 5437585
[No Abstract] [Full Text] [Related]
32. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
Santana-Davila R; Tefferi A; Holtan SG; Ketterling RP; Dewald GW; Knudson RA; Steensma DP; Chen D; Hoyer JD; Hanson CA
Leuk Res; 2008 Dec; 32(12):1927-30. PubMed ID: 18538839
[TBL] [Abstract][Full Text] [Related]
33. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
Tefferi A
Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
[TBL] [Abstract][Full Text] [Related]
34. Extramedullary blast transformation in the central nervous system in idiopathic myelofibrosis.
Barnes HM; Prchal JT; Scott CW
Am J Hematol; 1981 Nov; 11(3):305-8. PubMed ID: 7315844
[TBL] [Abstract][Full Text] [Related]
35. [The polymorphism of myeloproliferative tumor processes].
Brilliant MD; Domracheva EV; Tikhonova LIu; Vorob'ev AI
Ter Arkh; 1988; 60(5):3-9. PubMed ID: 3175925
[No Abstract] [Full Text] [Related]
36. [DIAGNOSIS OF MYELOFIBROSIS AND OSTEOMYELOSCLEROSIS].
PAPAGEORGIOU A
Dtsch Med Wochenschr; 1965 Mar; 90():436-7. PubMed ID: 14242203
[No Abstract] [Full Text] [Related]
37. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
Thiele J; Kvasnicka HM; Orazi A
Semin Hematol; 2005 Oct; 42(4):184-95. PubMed ID: 16210032
[TBL] [Abstract][Full Text] [Related]
38. Myeloproliferative disorder and tuberculosis.
Herman I
Calif Med; 1966 Oct; 105(4):287-90. PubMed ID: 5976885
[No Abstract] [Full Text] [Related]
39. [New molecular markers within the chronic myeloproliferative disorders. I: the PRV-1 gene].
Larsen TS; Pallisgaard N; Christensen JH; Gram-Hansen P; Kerndrup GB; Møller MB; Hasselbalch HC
Ugeskr Laeger; 2006 Sep; 168(39):3295-9. PubMed ID: 17032591
[TBL] [Abstract][Full Text] [Related]
40. [Clinical conference: Prognostic importance of medullary fibrosis in chronic myeloid leukemia].
Bryon PA; Fiere D; Revol L
Nouv Rev Fr Hematol; 1975; 15(2):303-4. PubMed ID: 126443
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
